Clinical Trial Update: Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission [Phase 3]

View source ↗

Summary

Phase 3 trial comparing etanercept monotherapy to methotrexate monotherapy for maintenance of remission in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Etanercept (etanercept)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2020-12-19